Jefferies Upgrades Arbutus Biopharma (ABUS) to Buy

February 2, 2022 2:49 AM EST
Get Alerts ABUS Hot Sheet
Price: $2.90 -3.65%

Rating Summary:
    7 Buy, 2 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 17 | Down: 33 | New: 11
Join SI Premium – FREE

Jefferies analyst Dennis Ding upgraded Arbutus Biopharma (NASDAQ: ABUS) from Hold to Buy with a price target of $5.00 (from $4.00).

For an analyst ratings summary and ratings history on Arbutus Biopharma click here. For more ratings news on Arbutus Biopharma click here.

Shares of Arbutus Biopharma closed at $2.92 yesterday.

You May Also Be Interested In

Related Categories

Analyst PT Change, Upgrades